Showing results (71-80 of 230) with videos related to

Sort By:
Pageof 23
The American Journal of Cardiology|April 14, 2009
Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitusLisette Okkels Jensen, Michael Maeng, Gary S Mintz, et al.
American Heart Journal|June 22, 2015
Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarctionLisette Okkels Jensen, Christian Juhl Terkelsen, Erzsébet Horváth-Puhó, et al.
The American Journal of Cardiology|January 27, 2009
Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trialMichael Maeng, Lisette Okkels Jensen, Anders Michael Galloe, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)Marcel A Beijk, Franz-Josef Neumann, Marcus Wiemer, et al.
Circulation. Cardiovascular Interventions|November 15, 2011
Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarctionChristian J Terkelsen, Lisette O Jensen, Hans H Tilsted, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 19, 2025
Myocardial Infarction and All-Cause Mortality Following Percutaneous Coronary Intervention Versus Conservative Treatment of Chronic Total Occlusions: A West Denmark Heart Registry StudyMarc Meller Søndergaard, Sanna Gunnarstein, Martin Kirk Christensen, et al.
Lancet (London, England)|March 18, 2008
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trialJohn A Ormiston, Patrick W Serruys, Evelyn Regar, et al.
JAMA|August 19, 2010
System delay and mortality among patients with STEMI treated with primary percutaneous coronary interventionChristian Juhl Terkelsen, Jacob Thorsted Sørensen, Michael Maeng, et al.
Danish Medical Journal|June 9, 2012
Catheter-based renal denervation for treatment of resistant hypertensionHenrik Vase, Ole Norling Mathiassen, Anne Kaltoft, et al.
Circulation. Cardiovascular Interventions|October 4, 2012
Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary interventionLars Jakobsen, Troels Niemann, Niels Thorsgaard, et al.
Pageof 23